Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and / or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile
Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and / or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile
Myo Htut, Paul Gerard Guy Richardson, Claudia Prada, Emma C. Scott et al.
Journal
Haematologica
Topics
Multiple Myeloma Research and Treatments
article
Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and / or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile
Myo Htut, Paul Gerard Guy Richardson, Claudia Prada, Emma C. Scott, Ira Gupta
article en
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(2)
Institutions
Oregon Health & Science University (US), City of Hope (US), Dana-Farber Cancer Institute (US), Dana-Farber/Harvard Cancer Center (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and / or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile — Myo Htut, Paul Gerard Guy Richardson, et al. · Haematologica (2024) | TGRS Research Map | TGRS